Clinical Trials Logo

Clinical Trial Summary

This multicenter Registry is to assess whether the use of pharmacogenomic data results in a meaningful change in a subject's drug or dose regimen. In addition, the Registry will evaluate the relationship between adverse drug reactions (ADR) and genotype and assess resource utilization (emergency department visits and hospitalizations) associated with ADR.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort


Related Conditions & MeSH terms


NCT number NCT01970709
Study type Observational [Patient Registry]
Source Renaissance RX
Contact
Status Active, not recruiting
Phase N/A
Start date November 2013

See also
  Status Clinical Trial Phase
Recruiting NCT02081872 - Utility of PharmacoGenomics for Reducing Adverse Drug Effects N/A
Recruiting NCT02095769 - Pharmacogenomic Testing Of the Elderly To Reduce Morbidity N/A